FAAH/MAGL inhibitor’s applications relating to learning and memory, neuropathic pain, anti-inflammatory, analgesic, improving synaptic plasticity, depression, anxiety, and other processes have been evaluated. The gene discussed is MGLL; the disease is major depressive disorder.